Literature DB >> 10797015

Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough.

S J Connolly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10797015      PMCID： PMC1117978          DOI： 10.1136/bmj.320.7244.1219

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Antithrombotic therapy in atrial fibrillation.

Authors:  A Laupacis; G Albers; J Dalen; M Dunn; W Feinberg; A Jacobson
Journal:  Chest       Date:  1995-10       Impact factor: 9.410

2.  Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1996-09-07       Impact factor: 79.321

3.  Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.

Authors:  L Kalra; G Yu; I Perez; A Lakhani; N Donaldson
Journal:  BMJ       Date:  2000-05-06

4.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors:  A Howitt; D Armstrong
Journal:  BMJ       Date:  1999-05-15

5.  National patterns of warfarin use in atrial fibrillation.

Authors:  R S Stafford; D E Singer
Journal:  Arch Intern Med       Date:  1996 Dec 9-23

6.  Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.

Authors: 
Journal:  Can J Cardiol       Date:  1998-05       Impact factor: 5.223

7.  Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

Authors:  M Sudlow; R Thomson; B Thwaites; H Rodgers; R A Kenny
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

8.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11
  8 in total
  4 in total

1.  Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care.

Authors:  D A Fitzmaurice; J Mant; E T Murray; F D Hobbs
Journal:  BMJ       Date:  2000-11-04

2.  Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.

Authors:  N Dudley
Journal:  BMJ       Date:  2000-09-09

3.  Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods.

Authors:  Leon Poller; Michelle Keown; Nikhil Chauhan; Anton M H P van den Besselaar; Armando Tripodi; Caroline Shiach; Jorgen Jespersen
Journal:  BMJ       Date:  2003-07-05

4.  A survey of opinion: When to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation?

Authors:  David Munn; Azmil H Abdul-Rahim; Urs Fischer; David J Werring; Thompson G Robinson; Jesse Dawson
Journal:  Eur Stroke J       Date:  2018-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.